Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Clearside Biomedical Inc.

    NASDAQ: CLSD · Real-Time Price · USD
    0.79
    0.02 (1.94%)
    At close: Jun 06, 2025, 3:59 PM
    0.82
    3.25%
    After-hours: Jun 06, 2025, 04:58 PM EDT

    Clearside Biomedical Statistics

    Share Statistics

    Clearside Biomedical has 77.71M shares outstanding. The number of shares has increased by 1.49% in one year.

    Shares Outstanding

    n/a
    		 77.71M

    Shares Change (YoY)

    n/a
    		 1.49%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 12.63%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 69

    FTD / Avg. Volume

    n/a
    		 0.04%

    Short Selling Information

    The latest short interest is 222.44K, so 0.29% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 222.44K

    Short % of Shares Out

    n/a
    		 0.29%

    Short % of Float

    n/a
    		 0.29%

    Short Ratio (days to cover)

    n/a
    		 1.9

    Valuation Ratios

    The PE ratio is -2.04 and the forward PE ratio is -1.25. Clearside Biomedical's PEG ratio is 0.18.

    PE Ratio

    n/a
    		 -2.04

    Forward PE

    n/a
    		 -1.25

    PS Ratio

    n/a
    		 42.14

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 -1.8

    P/FCF Ratio

    n/a
    		 -2.73

    PEG Ratio

    n/a
    		 0.18
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Clearside Biomedical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.44, with a Debt / Equity ratio of -0.02.

    Current Ratio

    n/a
    		 4.44

    Quick Ratio

    n/a
    		 4.44

    Debt / Equity

    n/a
    		 -0.02

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 -2.95

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $52,000

    Profits Per Employee

    n/a
    		 $-1,073,500

    Employee Count

    n/a
    		 32

    Asset Turnover

    n/a
    		 0.07

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -34.45% in the last 52 weeks. The beta is 2.06, so Clearside Biomedical's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.06

    52-Week Price Change

    n/a
    		 -34.45%

    50-Day Moving Average

    n/a
    		 0.85

    200-Day Moving Average

    n/a
    		 1

    Relative Strength Index (RSI)

    n/a
    		 40.86

    Average Volume (20 Days)

    n/a
    		 172,053

    Income Statement

    In the last 12 months, Clearside Biomedical had revenue of 1.66M and earned -34.35M in profits. Earnings per share was -0.47.

    Revenue

    n/a
    		 1.66M

    Gross Profit

    n/a
    		 1.51M

    Operating Income

    n/a
    		 -28.88M

    Net Income

    n/a
    		 -34.35M

    EBITDA

    n/a
    		 -24.35M

    EBIT

    n/a
    		 -24.57M

    Earnings Per Share (EPS)

    n/a
    		 -0.47
    Full Income Statement

    Balance Sheet

    The company has 20.02M in cash and 703K in debt, giving a net cash position of 19.32M.

    Cash & Cash Equivalents

    n/a
    		 20.02M

    Total Debt

    n/a
    		 703K

    Net Cash

    n/a
    		 19.32M

    Retained Earnings

    n/a
    		 -355.27M

    Total Assets

    n/a
    		 19.67M

    Working Capital

    n/a
    		 10.95M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -24.7M and capital expenditures -977K, giving a free cash flow of -25.68M.

    Operating Cash Flow

    n/a
    		 -24.7M

    Capital Expenditures

    n/a
    		 -977K

    Free Cash Flow

    n/a
    		 -25.68M

    FCF Per Share

    n/a
    		 -0.35
    Full Cash Flow Statement

    Margins

    Gross margin is 91.05%, with operating and profit margins of -1735.7% and -2064.42%.

    Gross Margin

    n/a
    		 91.05%

    Operating Margin

    n/a
    		 -1735.7%

    Pretax Margin

    n/a
    		 -2064.42%

    Profit Margin

    n/a
    		 -2064.42%

    EBITDA Margin

    n/a
    		 -1463.16%

    EBIT Margin

    n/a
    		 -1735.7%

    FCF Margin

    n/a
    		 -1542.97%

    Dividends & Yields

    CLSD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CLSD is $5, which is 541% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 541%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -28

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist